Citigroup’s Anika Therapeutics ANIK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$8.38K Sell
578
-15,640
-96% -$182K ﹤0.01% 5104
2025
Q4
$156K Buy
16,218
+16,043
+9,167% +$154K ﹤0.01% 4111
2025
Q3
$1.65K Sell
175
-4,025
-96% -$38.4K ﹤0.01% 5531
2025
Q2
$44.4K Sell
4,200
-4,859
-54% -$61.3K ﹤0.01% 4823
2025
Q1
$136K Sell
9,059
-1,169
-11% -$19.4K ﹤0.01% 4413
2024
Q4
$168K Sell
10,228
-1,295
-11% -$25.5K ﹤0.01% 4517
2024
Q3
$285K Buy
11,523
+8,168
+243% +$212K ﹤0.01% 4104
2024
Q2
$85K Buy
3,355
+504
+18% +$13.1K ﹤0.01% 4293
2024
Q1
$72.4K Buy
2,851
+724
+34% +$17.5K ﹤0.01% 4443
2023
Q4
$48.2K Buy
2,127
+2,036
+2,237% +$42.1K ﹤0.01% 4541
2023
Q3
$1.7K Sell
91
-19,925
-100% -$413K ﹤0.01% 5004
2023
Q2
$520K Sell
20,016
-11,465
-36% -$307K ﹤0.01% 3344
2023
Q1
$904K Buy
31,481
+8,885
+39% +$264K ﹤0.01% 2640
2022
Q4
$669K Sell
22,596
-11,784
-34% -$335K ﹤0.01% 2964
2022
Q3
$818K Buy
34,380
+9,442
+38% +$217K ﹤0.01% 2866
2022
Q2
$557K Buy
24,938
+3,559
+17% +$79.4K ﹤0.01% 3131
2022
Q1
$537K Sell
21,379
-11,653
-35% -$355K ﹤0.01% 3456
2021
Q4
$1.18M Buy
33,032
+12,356
+60% +$495K ﹤0.01% 3081
2021
Q3
$880K Sell
20,676
-25,402
-55% -$1.05M ﹤0.01% 3185
2021
Q2
$2M Buy
46,078
+4,330
+10% +$184K ﹤0.01% 2675
2021
Q1
$1.7M Buy
41,748
+32,316
+343% +$1.23M ﹤0.01% 2603
2020
Q4
$427K Buy
9,432
+2,542
+37% +$96.5K ﹤0.01% 4341
2020
Q3
$244K Sell
6,890
-12,050
-64% -$435K ﹤0.01% 4470
2020
Q2
$715K Buy
18,940
+1,207
+7% +$39.8K ﹤0.01% 3900
2020
Q1
$513K Sell
17,733
-173
-1% -$7K ﹤0.01% 3850
2019
Q4
$929K Sell
17,906
-25,277
-59% -$1.47M ﹤0.01% 3826
2019
Q3
$2.37M Buy
43,183
+8,893
+26% +$457K ﹤0.01% 2674
2019
Q2
$1.39M Buy
34,290
+26,324
+330% +$960K ﹤0.01% 3242
2019
Q1
$241K Sell
7,966
-1,982
-20% -$67.9K ﹤0.01% 4916
2018
Q4
$335K Sell
9,948
-90
-0.9% -$3.25K ﹤0.01% 4531
2018
Q3
$424K Buy
10,038
+6,283
+167% +$248K ﹤0.01% 4482
2018
Q2
$120K Sell
3,755
-1,160
-24% -$47.8K ﹤0.01% 5543
2018
Q1
$245K Sell
4,915
-850
-15% -$48K ﹤0.01% 4753
2017
Q4
$311K Sell
5,765
-2,728
-32% -$151K ﹤0.01% 4606
2017
Q3
$493K Sell
8,493
-10,462
-55% -$547K ﹤0.01% 4136
2017
Q2
$935K Sell
18,955
-771
-4% -$35.5K ﹤0.01% 3388
2017
Q1
$856K Sell
19,726
-12,641
-39% -$603K ﹤0.01% 3382
2016
Q4
$1.58M Buy
32,367
+22,101
+215% +$1.02M ﹤0.01% 3201
2016
Q3
$491K Buy
10,266
+1,993
+24% +$98.4K ﹤0.01% 3907
2016
Q2
$444K Sell
8,273
-2,464
-23% -$116K ﹤0.01% 3795
2016
Q1
$480K Buy
10,737
+9,266
+630% +$376K ﹤0.01% 4166
2015
Q4
$56K Sell
1,471
-288
-16% -$11K ﹤0.01% 5845
2015
Q3
$56K Sell
1,759
-841
-32% -$29.3K ﹤0.01% 5359
2015
Q2
$86K Sell
2,600
-124
-5% -$4.42K ﹤0.01% 5118
2015
Q1
$112K Buy
2,724
+598
+28% +$24.2K ﹤0.01% 4946
2014
Q4
$87K Sell
2,126
-3,311
-61% -$129K ﹤0.01% 5339
2014
Q3
$199K Buy
5,437
+1,188
+28% +$51.3K ﹤0.01% 4247
2014
Q2
$197K Buy
4,249
+279
+7% +$12.4K ﹤0.01% 4149
2014
Q1
$163K Sell
3,970
-3,727
-48% -$139K ﹤0.01% 4533
2013
Q4
$294K Buy
7,697
+2,864
+59% +$88.4K ﹤0.01% 4295
2013
Q3
$116K Sell
4,833
-1,264
-21% -$28.4K ﹤0.01% 4606
2013
Q2
$104K Buy
+6,097
New +$87.9K ﹤0.01% 4821

Other funds holding ANIK